Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance.
Vasilevska J, Cheng PF, Lehmann J, Ramelyte E, Gómez JM, Dimitriou F, Sella F; TuPro Consortium; Ferretti D, Salas-Bastos A, Jordaan WS, Levesque MP, Dummer R, Sommer L.
Vasilevska J, et al. Among authors: gomez jm.
Cell Rep Med. 2024 Jul 16;5(7):101611. doi: 10.1016/j.xcrm.2024.101611. Epub 2024 Jun 27.
Cell Rep Med. 2024.
PMID: 38942020
Free PMC article.